The ELISA human ghrelin test quantifies human ghrelin in serum, plasma, buffered solution or human cell culture medium. The dosage will only recognize natural and recombinant human ghrelin. Principle...
The ELISA human ghrelin test quantifies human ghrelin in serum, plasma, buffered solution or human cell culture medium. The dosage will only recognize natural and recombinant human ghrelin. Method Principle The ELISA solid phase sandwich test for human ghrelin (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
GHRL codes ghreline-obestatin preprotein, which generates ghrelin and l-obestatin. Ghrelin is a ligand of the type 1 growth hormone secretagogue receptor and is involved in regulating the release of growth hormone. Ghrelin has a stimulating effect on appetite, induces adiposity and stimulates the secretion of gastric acid. L-obostatin may be the GPR39 receptor ligand coupled with the orphan G protein and is involved in satiety and may have an appetite-reducing effect resulting in a decrease in food consumption.
Sensitivity
Sensitivity of the dosage: 11.8 pg/ml.
Measurement range
Dose range: 15.6-1.000.0 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 30 min.
Reproducibility
Coefficient of variation intra-dose 6%, inter-dose 8.5%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15511717 |
| Specifications |
| Accession number | Q9UBU3 |
| Dose range | 15.6-1.000.0 pg/ml |
| Sensitivity of the dosage | 11.8 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 51738 |
| Gene symbol(s) | MTLRP |
| Coefficient of inter-dose variation | 8.5% |
| Coefficient of intra-dose variation | 6% |
| Contents of kits | 96-well pre-coated plate, Stalcon, Stalcon, Dose buffer concentrate, Biotinylated detection antibody, Wash pad, Wash pad, Chromogen, Chromogen, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 Tests |
| Regulatory status | RUO |
| Synonym | Ghrelin GHRL |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 25 μl; serum, 25 μl; supernatant, 25 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 30 min |
Origin and customs
| Manufacturer ref. | BMS2192 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.